معرفی
Anthony (Tony) T. Dren, PhD, RPh, is a Consulting Professor in the Duke University School of Nursing. A registered pharmacist with more than three decades of experience in pre-clinical and clinical drug development, Dr. Dren brings extensive industry expertise to Duke’s graduate nursing programs.
Education
- PhD in Pharmacology, University of Michigan at Ann Arbor
- MS in Pharmacy, Duquesne University (Pittsburgh, PA)
Research Interests
Dr. Dren’s scholarly focus centers on the design, execution, monitoring, and reporting of Phase I–IV multi-center clinical trials. His work bridges pharmacology and advanced nursing practice, emphasizing rigorous methodologies for evaluating new therapeutic agents. Areas of particular depth include pre-clinical safety assessment, adaptive trial design, regulatory strategy, and the integration of pharmacokinetic–pharmacodynamic modeling into clinical research.
Scientific Awards & Honors
- Holds ten patents in drug development and pharmaceutical sciences.
- Author of numerous peer-reviewed articles in leading pharmacology and clinical research journals.
Advising & Grant Activity
While the directory does not enumerate specific grants or funded projects, Dr. Dren’s long-standing collaboration with industry leaders such as Abbott Laboratories, Burroughs Wellcome Co., and Cato Research Ltd. indicates substantial extramural support. He has implemented, managed, monitored, and reported on more than 40 drug-development clinical trials, providing mentorship and practical guidance to Duke Master of Science in Nursing and Doctor of Nursing Practice students engaged in translational research.
Labs & Teams
Although no dedicated laboratory is referenced, Dr. Dren’s role as Consulting Professor implies active participation in multidisciplinary teams within the School of Nursing, interfacing with biostatistics, clinical pharmacology units, and external contract research organizations.
